Earlier Onset of Complications in Youth With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the risk of complications in youth with type 2 diabetes. RESEARCH DESIGN AND METHODS: Population-based cohorts of 342 youth (1–18 years of age) with prevalent type 2 diabetes, 1,011 youth with type 1 diabetes, and 1,710 nondiabetic control youth were identified between 1986 and 2007 from a clinical registry and linked to health care records to assess long-term outcomes using ICD-9CM and ICD-10CA codes. RESULTS: Youth with type 2 diabetes had an increased risk of any complication (hazard ratio 1.47 [95% CI 1.02–2.12]). Significant adverse clinical factors included age at diagnosis (1.08 [1.02–2.12]), HbA1c (1.06 [1.01–1.12]), and, surprisingly, renin-angiotensin-aldosterone system (RAAS) inhibitor use (1.75 [1.27–2.41]). HNF-1α G319S polymorphism was protective in the type 2 diabetes cohort (0.58 [0.34–0.99]). Kaplan-Meier statistics revealed an earlier diagnosis of renal and neurologic complications in the type 2 diabetes cohort, manifesting within 5 years of diagnosis. No difference in retinopathy was seen. Cardiovascular and cerebrovascular diseases were rare; however, major complications (dialysis, blindness, or amputation) started to manifest 10 years after diagnosis in the type 2 diabetes cohort. Youth with type 2 diabetes had higher rates of all outcomes than nondiabetic control youth and an overall 6.15-fold increased risk of any vascular disease. CONCLUSIONS: Youth with type 2 diabetes exhibit complications sooner than youth with type 1 diabetes. Younger age at diagnosis is potentially protective, and glycemic control is an important modifiable risk factor. The unexpected adverse association between RAAS inhibitor use and outcome is likely a confounder by indication; however, further evaluation in young people is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Standards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
Type 2 diabetes among North adolescents: An epidemiologic health perspective
Fagot-Campagna, A., Pettitt, D. J., Engelgau, M. M., Burrows, N. R., Geiss, L. S., Valdez, R., Beckles, G. L. A., Saaddine, J., Gregg, E. W., Williamson, D. F., et al. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.105141 · Cited by 1,285
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
The global spread of type 2 diabetes mellitus in children and adolescents
Pinhas-Hamiel, O., & Zeitler, P. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.042 · Cited by 652
Research works printed but not linked: 33
- Kitagawa, 1998, Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat, Clin Pediatr (Phila), 37, 111, 10.1177/000992289803700208 · DOI · Paper page
- Amed, 2010, Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: a prospective national surveillance study, Diabetes Care, 33, 786, 10.2337/dc09-1013 · DOI · Paper page
- Sellers, 2012, Clinical and demographic characteristics of type 2 diabetes in youth at diagnosis in Manitoba and northwestern Ontario (2006-2011), Can J Diabetes, 36, 114, 10.1016/j.jcjd.2012.04.013 · DOI
- Girach, 2006, Diabetic microvascular complications—can the presence of one predict the development of another?, J Diabetes Complications, 20, 228, 10.1016/j.jdiacomp.2006.03.001 · DOI
- Remuzzi, 2002, Clinical practice. Nephropathy in patients with type 2 diabetes, N Engl J Med, 346, 1145, 10.1056/NEJMcp011773 · DOI · Paper page
- Pinhas-Hamiel, 2007, Acute and chronic complications of type 2 diabetes mellitus in children and adolescents, Lancet, 369, 1823, 10.1016/S0140-6736(07)60821-6 · DOI · Paper page
- Sellers, 2002, The prevalence of the HNF-1alpha G319S mutation in Canadian aboriginal youth with type 2 diabetes, Diabetes Care, 25, 2202, 10.2337/diacare.25.12.2202 · DOI
- Triggs-Raine, 2002, HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community, Proc Natl Acad Sci U S A, 99, 4614, 10.1073/pnas.062059799 · DOI
- Harries, 2008, Diabetes susceptibility in the Canadian Oji-Cree population is moderated by abnormal mRNA processing of HNF1A G319S transcripts, Diabetes, 57, 1978, 10.2337/db07-1633 · doi:10.2337/db07-1633
- Dart, 2012, High burden of kidney disease in youth-onset type 2 diabetes, Diabetes Care, 35, 1265, 10.2337/dc11-2312 · DOI · Paper page
- Dart, 2011, Validation of a pediatric diabetes case definition using administrative health data in Manitoba, Canada, Diabetes Care, 34, 898, 10.2337/dc10-1572 · DOI · Paper page
- Roos, 1993, Registries and administrative data: organization and accuracy, Med Care, 31, 201, 10.1097/00005650-199303000-00002 · DOI · Paper page
- Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2008, Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada, S162
- Sellers, 2000, Diabetes-associated autoantibodies in aboriginal children, Lancet, 355, 1156, 10.1016/S0140-6736(00)02067-5 · DOI
- Yokoyama, 2000, Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan, Kidney Int, 58, 302, 10.1046/j.1523-1755.2000.00166.x · DOI · Paper page
- Ettinger, 2005, Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus, J Pediatr, 147, 67, 10.1016/j.jpeds.2005.02.003 · DOI
- Eppens, 2006, Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes, Diabetes Care, 29, 1300, 10.2337/dc05-2470 · DOI · Paper page
- TODAY Study Group, 2013, Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial, Diabetes Care, 36, 1735, 10.2337/dc12-2420 · DOI · Paper page
- Pavkov, 2006, Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians, JAMA, 296, 421, 10.1001/jama.296.4.421 · DOI · Paper page
- Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2008, Chronic kidney disease in diabetes, Can J Diabetes, 32, S126
- Sellers, 2009, Macroalbuminuria and renal pathology in First Nation youth with type 2 diabetes, Diabetes Care, 32, 786, 10.2337/dc08-1828 · doi:10.2337/dc08-1828
- Samuel, 2012, Incidence and causes of end-stage renal disease among aboriginal children and young adults, CMAJ, 184, E758, 10.1503/cmaj.120427 · doi:10.1503/cmaj.120427
- Bronson-Castain, 2009, Adolescents with type 2 diabetes: early indications of focal retinal neuropathy, retinal thinning, and venular dilation, Retina, 29, 618, 10.1097/IAE.0b013e31819a988b · DOI
- McGrath, 1999, Early presentation of type 2 diabetes mellitus in young New Zealand Maori, Diabetes Res Clin Pract, 43, 205, 10.1016/S0168-8227(99)00003-0 · DOI
- Chuback, 2007, Foot abnormalities in Canadian aboriginal adolescents with type 2 diabetes, Diabet Med, 24, 747, 10.1111/j.1464-5491.2007.02133.x · DOI
- Scott, 2006, First national audit of the outcomes of care in young people with diabetes in New Zealand: high prevalence of nephropathy in Maori and Pacific Islanders, N Z Med J, 119, U2015
- Okudaira, 2000, Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese type 2 diabetes, J Diabetes Complications, 14, 281, 10.1016/S1056-8727(00)00114-8 · DOI
- Krakoff, 2003, Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes, Diabetes Care, 26, 76, 10.2337/diacare.26.1.76 · DOI · Paper page
- Yokoyama, 1998, High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis, Diabetes Care, 21, 1080, 10.2337/diacare.21.7.1080 · DOI · Paper page
- TODAY Study Group, 2013, Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial, Diabetes Care, 36, 1772, 10.2337/dc12-2387 · DOI · Paper page
- Olsen, 2004, The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes, J Diabetes Complications, 18, 160, 10.1016/S1056-8727(03)00073-4 · DOI
- Schmidt, 2013, Primary prevention of cardiovascular complications in type II diabetes patients using aspirin: a complicated tale, Am J Ther, 10.1097/MJT.0b013e3181afbf17 · DOI
- Mustard, 1999, Assessing ecologic proxies for household income: a comparison of household and neighbourhood level income measures in the study of population health status, Health Place, 5, 157, 10.1016/S1353-8292(99)00008-8 · DOI · Paper page
Cited by
Dabelea, D., Stafford, J. M., Mayer-Davis, E. J., D’Agostino, R., Dolan, L., Imperatore, G., Linder, B., Lawrence, J. M., Marcovina, S. M., Mottl, A. K., et al. (2017) · JAMA · doi:10.1001/jama.2017.0686 · Cited by 700
The changing face of diabetes complications
Gregg, E. W., Sattar, N., & Ali, M. K. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30010-9 · Cited by 612
Long-term complications in youth-onset type 2 diabetes
TODAY Study Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100165 · Cited by 546
Young-onset type 2 diabetes mellitus — implications for morbidity and mortality
Magliano, D. J., Sacre, J. W., Harding, J. L., Gregg, E. W., Zimmet, P. Z., & Shaw, J. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0334-z · Cited by 483
Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities
Nadeau, K. J., Anderson, B. J., Berg, E. G., Chiang, J. L., Chou, H., Copeland, K. C., Hannon, T. S., Huang, T. T.-K., Lynch, J. L., Powell, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1066 · Cited by 381
“Rapid progression of complications is also seen; current evidence in First Nations youth with type 2 diabetes shows that renal and neurological complications begin to appear within 5 years of diagnosis, and major complications (dialysis, blindness, or amputation) start to manifest 10 years after diagnosis (21,22).”
BackgroundSelf-citation
Metadata
- Authors
- Dart, A. B., Martens, P. J., Rigatto, C., Brownell, M. D., Dean, H. J., & Sellers, E. A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-01-11
- Volume
- 37
- Issue
- 2
- Pages
- 436-443
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2098849487
- Cited by
- 251
- References
- 6
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.